Clinical and public health consequences of multidrug-resistant bacterial infections in Tanzanian children
Mission Hall, Room 1407
Register for Zoom
Antimicrobial resistance (AMR) is a global public health threat. Sub-Saharan Africa has been hardly hit by the burden of AMR infections. It is estimated that in 2019, there were 27·3 deaths per 100 000 (20·9–35·3) attributable to bacterial AMR and 114·8 deaths per 100 000 (90·4–145·3) associated with bacterial AMR.
Tanzania, the lower-middle-income country, is also hardly hit with the burden of AMR. Addressing the burden of antimicrobial resistance through early detection remains critical.
Professor Joel P. Manyahi, MD, MMed, PhD
Joel Manyahi is an associate professor in microbiology at Muhimbili University of Health and Allied Sciences (MUHAS) and a consultant in clinical microbiology at Muhimbili National Hospital in Tanzania. He is the current head of the department of microbiology and immunology at MUHAS.
Joel has been involved in research and consulting involving antimicrobial resistance and the diagnosis, control, and prevention of infectious diseases in a resource-limited setting for the past 12 years. His desire has been to improve the diagnosis, control, and prevention of infectious diseases by focusing more on improving diagnostic stewardship. He has more than 40 publications in peer review journals.
Working with the American Society for Microbiology in Tanzania, he has been able to build the local capacities of the laboratories in the diagnosis of infectious diseases as well as improve surveillance of health care-associated infections and antimicrobial resistance.